Medicare Enrolled

Dr. Hannah Wangberg

Allergy & Immunology · San Diego, CA
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
Low-engagement
200 W ARBOR DR, San Diego, CA 92103
6194710434
In practice since 2015 (10 years)
NPI: 1306233663 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Wangberg from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Wangberg? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Wangberg

Dr. Hannah Wangberg is an allergy & immunology specialist in San Diego, CA, with 10 years of NPI registration. Based on federal Medicare data, Dr. Wangberg performed 8,216 Medicare services across 283 unique beneficiaries.

Between the years covered by Open Payments, Dr. Wangberg received a total of $6,115 from 26 pharmaceutical and/or device companies across 273 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in allergy & immunology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Wangberg is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 10 years in practice ▲ Top 27% volume in CA $6,115 industry payments

Medicare Practice Summary

Medicare Utilization ↗
8,216
Medicare services
Top 27% in CA for allergy & immunology
283
Unique beneficiaries
$20
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~822 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Injection, mepolizumab, 1 mg 3,303 $21 $100
Omalizumab injection (Xolair) for asthma/allergy 3,272 $23 $92
Allergy skin test
A diagnostic test performed to identify specific allergies by applying or introducing allergenic extracts to the body. The procedure measures the patient's immune response to various potential allergens.
1,262 $3 $14
Drug injection, under skin or into muscle
A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle.
156 $12 $46
Allergy injection therapy, multiple injections
A professional service involving the administration of multiple allergen injections.
63 $10 $40
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
47 $107 $350
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
45 $128 $453
Allergen injection administration
Professional service for the administration of a single allergen injection.
23 $9 $33
Allergy test using ingested items, initial 2 hours
This procedure involves testing for allergies by having the patient ingest specific items over an initial two-hour period.
16 $106 $400
New patient office visit, complex (60-74 min) 16 $175 $598
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
13 $152 $491
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$6,115
Total received (2018-2024)
Avg $874/year across 7 years
Top 33% in CA for allergy & immunology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
26
Companies
273
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$6,047 (98.9%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$68 (1.1%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,719
2023
$2,142
2022
$1,183
2021
$846
2020
$178
2019
$30
2018
$16

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
GENZYME CORPORATION
$412
LEO Pharma Inc.
$230
Takeda Pharmaceuticals U.S.A., Inc.
$159
GlaxoSmithKline, LLC.
$143
Regeneron Healthcare Solutions, Inc.
$143
Blueprint Medicines Corporation
$78
CSL Behring
$77
Novartis Pharmaceuticals Corporation
$74
SANOFI-AVENTIS U.S. LLC
$68
Grifols USA, LLC
$65
Pharming Healthcare, Inc.
$43
AstraZeneca Pharmaceuticals LP
$39
BioCryst US Sales Co., LLC
$36
Genentech USA, Inc.
$32
PFIZER INC.
$26
Lilly USA, LLC
$24
kaleo, Inc.
$24
ALK-Abello, Inc
$23
Janssen Biotech, Inc.
$21
Top 3 companies account for 46.6% of 2024 payments
All-time payments by company (2018-2024) ›
GlaxoSmithKline, LLC.
$1,378
GENZYME CORPORATION
$917
Takeda Pharmaceuticals U.S.A., Inc.
$616
Regeneron Healthcare Solutions, Inc.
$476
AstraZeneca Pharmaceuticals LP
$424
Boehringer Ingelheim Pharmaceuticals, Inc.
$247
Grifols USA, LLC
$244
LEO Pharma Inc.
$230
CSL Behring
$212
Novartis Pharmaceuticals Corporation
$190
PFIZER INC.
$167
ALK-Abello, Inc
$162
Pharming Healthcare, Inc.
$142
kaleo, Inc.
$136
Genentech USA, Inc.
$107
Amgen Inc.
$100
SANOFI-AVENTIS U.S. LLC
$87
Blueprint Medicines Corporation
$78
BioCryst US Sales Co., LLC
$66
Lilly USA, LLC
$24
HOSPIRA, INC.
$24
Janssen Biotech, Inc.
$21
Incyte Corporation
$20
Bio Products Laboratory USA, Inc.
$18
Braintree Laboratories, Inc.
$17
Kaleo, Inc.
$12
Top 3 companies account for 47.6% of all-time payments
Associated products mentioned in payments ›
ADBRY · AREXVY · AUVI-Q · AYVAKIT · CUTAQUIG · CUVITRU · DUPIXENT · ENTYVIO · EOHILIA · EUCRISA · FASENRA · Gammaplex · Grastek · HYQVIA · Hizentra · NUCALA · OFEV · OMVOH · OPZELURA · ORLADEYO · Orladeyo · PANZYGA · RUCONEST · SPIRIVA RESPIMAT · STELARA · STIOLTO RESPIMAT · SUTAB · TAKHZYRO · TEZSPIRE · TRELEGY ELLIPTA · XOLAIR · Xembify · Xolair
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (99%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for an allergy & immunology specialist in San Diego?
Compare allergy & immunologists in the San Diego area by procedure volume, costs, and industry payment transparency.
Browse allergy & immunologists nearby

Geographic Context

Allergy & immunologists within 10 mi
49
Per 100K population
1.5
County median income
$102,285
Nearest hospital
UC SAN DIEGO HEALTH HILLCREST - HILLCREST MED CTR
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Wangberg is a mixed practice specialist, with above-average Medicare volume (top 27% in CA), with low-engagement industry engagement.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Wangberg experienced with injection, mepolizumab, 1 mg?
Based on Medicare claims data, Dr. Wangberg performed 3,303 injection, mepolizumab, 1 mg services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Wangberg receive payments from pharmaceutical companies?
Yes. Dr. Wangberg received a total of $6,115 from 26 companies across 273 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Wangberg's costs compare to other allergy & immunologists in San Diego?
Dr. Wangberg's average Medicare payment per service is $20. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Wangberg) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →